Avoiding hERG-liability in drug design via synergetic combinations of different (Q)SAR methodologies and data sources: a case study in an industrial setting

Table 8 Combining statistical models

Models	ACC	BA	SENS	SPEC	PPV	NPV	MCC	KAPPA
RF_{Merck+ChEMBL (2:5)}	0.84	0.75	0.59	0.91	0.65	0.89	0.52	0.51
SOHN_{Merck+ChEMBL (2:5)}	0.83	0.76	0.63	0.89	0.62	0.89	0.52	0.52
RF-SOHN_{Merck+ChEMBL (2:5)}	0.85	0.78	0.66	0.91	0.67	0.90	0.57	0.57

ISSN: 1758-2946